Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes - Real-World Data From Odyssee Study.

Leproust, S; Dallongeville, J; Valensi, P; Boutmy, E; Moisan, C; Chanut-Vogel, C; de Pouvourville, G

Leproust, S; Dallongeville, J; Valensi, P; Boutmy, E; Moisan, C; Chanut-Vogel, C; de Pouvourville, G.

Affiliation

Leproust S; Merck (MSD France), Paris, France.
Dallongeville J; INSERM U744, Lille, France.
Valensi P; Service d'Endocrinologie-Diabétologie-Nutrition, Bondy, France.
Boutmy E; Cegedim Strategic Data, Boulogne-Billancourt, France.
Moisan C; Merck (MSD France), Paris, France.
Chanut-Vogel C; Laboratoires MSD France, Courbevoie, France.
de Pouvourville G; ESSEC, Cergy-Pontoise, France.

Value Health ; 17(7): A334-5, 2014 Nov.

Article in En | MEDLINE | ID: mdl-27200591

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: France Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google